findmyKOL
Clinical trialNCT06689956RecruitingObservational

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

SponsorMayo ClinicEnrollment212FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA1 Endometrial Cancer FIGO 2023Stage IA2 Endometrial Cancer FIGO 2023
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medical University of Vienna

    Vienna, Austria

    Christoph Grimm, MD
    Recruiting
Brazil
  • Ac Camargo Cancer Center

    São Paulo, Brazil

    Glauco Baiocchi, MD, PhD
    Recruiting
Canada
  • Sunnybrook Health Sciences, University of Toronto

    Toronto, Ontario, Canada

    Allan Covens, MD
    Recruiting
  • Hopital Maisonneuve Rosemont

    Montreal, Quebec, Canada

    Sabrina Piedimonte, MD
    Recruiting
France
  • Institut Universitaire Du Cancer Toulouse Oncopole

    Toulouse, France

    Giulio Ricotta, MD
    Not, yet, recruiting
Germany
  • University Hospital Essen

    Essen, Germany

    Paul Buderath, MD
    Not, yet, recruiting
Israel
  • Meir Medical Center, Faculty of Medicine - Tel-Aviv University

    Kefar Sava, Israel

    Mario Beiner, MD
    Not, yet, recruiting
Italy
  • Ospedale Michele E Pietro Ferrero

    Verduno, CN, Italy

    Alessandro Buda, MD
    Not, yet, recruiting
  • Irccs Fondazione San Gerardo Dei Tintori

    Monza, MB, Italy

    Fabio Landon, MD
    Not, yet, recruiting
  • European Institute of Oncology

    Milan, MI, Italy

    Francesco Multinu, MD
    Recruiting
  • Fondazione Irccs Istituto Nazionale Tumori

    Milan, MI, Italy

    Francesco Raspagliesi, MD
    Recruiting
  • Policlinico Universitario Fondazione Agostino Gemelli

    Roma, RM, Italy

    Francesco Fanfani, MD
    Recruiting
  • University of Udine

    Udine, UD, Italy

    Giuseppe Vizzielli, MD, PhD
    Not, yet, recruiting
  • Istituto Nazionale Tumori, Irccs, Fondazione G. Pascale

    Naples, Italy

    Vito Chiantera, MD
    Not, yet, recruiting
Spain
  • Hospital Materno Infantil Las Palmas

    Las Palmas, Spain

    Octavio Arencibia Sanchez, MD, PhD
    Recruiting
  • Hospital Universitario la Paz

    Madrid, Spain

    Ignacio Zapardiel, MD
    Recruiting
Switzerland
  • Ospedale Regionale Di Lugano, Civico

    Lugano, Switzerland

    Andrea Papadia, MD, PhD
    Recruiting
United States
  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

    Gretchen E. Glaser, MD
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Nadeem R. Abu-Rustum, MD
    Recruiting
  • Houston Methodist Hospital

    Houston, Texas, United States

    Pedro T. Ramirez, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Dec 2024
Primary completion
31 Oct 2029
Completion
31 Oct 2029
Last update posted
19 Feb 2026
Registered enrollment
212
Registry id
NCT06689956

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.